In addition, UALCAN program analysis also showed that the expression of LINC01615 in diverse cancer types such as bladder carcinoma (BLCA), head and neck squamous cell carcinoma (HNSC), and sarcoma (SARC) was notably upregulated (Figure 6B). This evidence concerns the gene LINC01615 and bladder transitional cell carcinoma.